201 related articles for article (PubMed ID: 33422435)
21. Rapid assay brain natriuretic peptide and troponin I in patients hospitalized with decompensated heart failure (from the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness Trial).
Shah MR; Hasselblad V; Tasissa G; Christenson RH; Binanay C; O'Connor CM; Ohman EM; Stevenson LW; Califf RM
Am J Cardiol; 2007 Nov; 100(9):1427-33. PubMed ID: 17950802
[TBL] [Abstract][Full Text] [Related]
22. Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure.
Fonarow GC; Peacock WF; Phillips CO; Givertz MM; Lopatin M;
J Am Coll Cardiol; 2007 May; 49(19):1943-50. PubMed ID: 17498579
[TBL] [Abstract][Full Text] [Related]
23. Natriuretic peptides and the prevalence of congestive heart failure in patients with pacemakers.
Gwechenberger M; Huelsmann M; Graf S; Berger R; Bonderman D; Stanek B; Rauscha F; Pacher R
Eur J Clin Invest; 2004 Dec; 34(12):811-7. PubMed ID: 15606723
[TBL] [Abstract][Full Text] [Related]
24. Changes of natriuretic peptides predict hospital admissions in patients with chronic heart failure: a meta-analysis.
Savarese G; Musella F; D'Amore C; Vassallo E; Losco T; Gambardella F; Cecere M; Petraglia L; Pagano G; Fimiani L; Rengo G; Leosco D; Trimarco B; Perrone-Filardi P
JACC Heart Fail; 2014 Apr; 2(2):148-58. PubMed ID: 24720923
[TBL] [Abstract][Full Text] [Related]
25. Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.
Grewal J; McKelvie RS; Persson H; Tait P; Carlsson J; Swedberg K; Ostergren J; Lonn E
Am J Cardiol; 2008 Sep; 102(6):733-7. PubMed ID: 18773998
[TBL] [Abstract][Full Text] [Related]
26. Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations.
Mueller C; McDonald K; de Boer RA; Maisel A; Cleland JGF; Kozhuharov N; Coats AJS; Metra M; Mebazaa A; Ruschitzka F; Lainscak M; Filippatos G; Seferovic PM; Meijers WC; Bayes-Genis A; Mueller T; Richards M; Januzzi JL;
Eur J Heart Fail; 2019 Jun; 21(6):715-731. PubMed ID: 31222929
[TBL] [Abstract][Full Text] [Related]
27. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.
Yasue H; Yoshimura M; Sumida H; Kikuta K; Kugiyama K; Jougasaki M; Ogawa H; Okumura K; Mukoyama M; Nakao K
Circulation; 1994 Jul; 90(1):195-203. PubMed ID: 8025996
[TBL] [Abstract][Full Text] [Related]
28. Utility of B-type natriuretic peptide and N-terminal pro B-type natriuretic peptide in evaluation of respiratory failure in critically ill patients.
Jefic D; Lee JW; Jefic D; Savoy-Moore RT; Rosman HS
Chest; 2005 Jul; 128(1):288-95. PubMed ID: 16002948
[TBL] [Abstract][Full Text] [Related]
29. B-type natriuretic Peptide predicts clinical presentations and ventricular overloading in patients with heart failure.
Joung BY; Park BE; Kim DS; Hong BK; Kim DY; Cho YH; Lee SH; Yoon YW; Kim HS; Kim JH; Kwon HM
Yonsei Med J; 2003 Aug; 44(4):623-34. PubMed ID: 12950118
[TBL] [Abstract][Full Text] [Related]
30. Extremely elevated BNP in acute heart failure: Patient characteristics and outcomes.
Omar HR; Guglin M
Int J Cardiol; 2016 Sep; 218():120-125. PubMed ID: 27232923
[TBL] [Abstract][Full Text] [Related]
31. Correlation between microvascular dysfunction and B-type natriuretic peptide levels in non-ischemic heart failure patients with cardiac fibrosis.
Hirakawa K; Yamamuro M; Uemura T; Takashio S; Kaikita K; Utsunomiya D; Nakayama M; Yamamoto E; Yamashita Y; Hokimoto S; Tsujita K
Int J Cardiol; 2017 Feb; 228():881-885. PubMed ID: 27889555
[TBL] [Abstract][Full Text] [Related]
32. Distinguishable optimal levels of plasma B-type natriuretic peptide in heart failure management based on complicated atrial fibrillation.
Koitabashi T; Inomata T; Niwano S; Nishii M; Takeuchi I; Nakano H; Shinagawa H; Takehana H; Izumi T
Int Heart J; 2005 May; 46(3):453-64. PubMed ID: 16043941
[TBL] [Abstract][Full Text] [Related]
33. B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure: comparison between systolic and diastolic heart failure.
Iwanaga Y; Nishi I; Furuichi S; Noguchi T; Sase K; Kihara Y; Goto Y; Nonogi H
J Am Coll Cardiol; 2006 Feb; 47(4):742-8. PubMed ID: 16487838
[TBL] [Abstract][Full Text] [Related]
34. Obesity, brain natriuretic peptide levels and mortality in patients hospitalized with heart failure and preserved left ventricular systolic function.
Stavrakis S; Pakala A; Thomas J; Chaudhry MA; Thadani U
Am J Med Sci; 2013 Mar; 345(3):211-7. PubMed ID: 23422653
[TBL] [Abstract][Full Text] [Related]
35. B-Type Natriuretic Peptide During Treatment With Sacubitril/Valsartan: The PARADIGM-HF Trial.
Myhre PL; Vaduganathan M; Claggett B; Packer M; Desai AS; Rouleau JL; Zile MR; Swedberg K; Lefkowitz M; Shi V; McMurray JJV; Solomon SD
J Am Coll Cardiol; 2019 Mar; 73(11):1264-1272. PubMed ID: 30846338
[TBL] [Abstract][Full Text] [Related]
36. Usefulness of B-type natriuretic peptide levels in predicting hemodynamic perturbations after heart transplantation despite preserved left ventricular systolic function.
Park MH; Scott RL; Uber PA; Harris BC; Chambers R; Mehra MR
Am J Cardiol; 2002 Dec; 90(12):1326-9. PubMed ID: 12480042
[TBL] [Abstract][Full Text] [Related]
37. Brain natriuretic peptide and n-terminal brain natriuretic peptide in the diagnosis of heart failure in patients with acute shortness of breath.
Lainchbury JG; Campbell E; Frampton CM; Yandle TG; Nicholls MG; Richards AM
J Am Coll Cardiol; 2003 Aug; 42(4):728-35. PubMed ID: 12932611
[TBL] [Abstract][Full Text] [Related]
38. Lower rather than higher levels of B-type natriuretic peptides (NT-pro-BNP and BNP) predict short-term mortality in end-stage heart failure patients treated with nesiritide.
Miller WL; Burnett JC; Hartman KA; Henle MP; Burritt MF; Jaffe AS
Am J Cardiol; 2005 Sep; 96(6):837-41. PubMed ID: 16169373
[TBL] [Abstract][Full Text] [Related]
39. Brain natriuretic peptide and N-terminal proBNP in chronic haemodialysis patients.
Racek J; Králová H; Trefil L; Rajdl D; Eiselt J
Nephron Clin Pract; 2006; 103(4):c162-72. PubMed ID: 16645318
[TBL] [Abstract][Full Text] [Related]
40. Genetic variation in the natriuretic peptide system and heart failure.
Lanfear DE
Heart Fail Rev; 2010 May; 15(3):219-28. PubMed ID: 18850266
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
